Get the Stockscreener App
0.2994
0.96%
0.0171
Bionomics Ltd Adr stock is traded at $0.2994, with a volume of 96,469.
It is up +0.96% in the last 24 hours and down -3.55% over the past month.
Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
See More
Previous Close:
$0.2823
Open:
$0.3
24h Volume:
96,469
Relative Volume:
0.01
Market Cap:
$4.87M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-0.092
EPS:
-3.2558
Net Cash Flow:
-
1W Performance:
-10.04%
1M Performance:
-3.55%
6M Performance:
-75.85%
1Y Performance:
-86.00%
1-Day Range:
$0.28
$0.30
1-Week Range:
$0.2701
$0.3265
52-Week Range:
$0.177
$2.12
Bionomics Ltd Adr Stock (BNOX) Company Profile
Name
Bionomics Ltd Adr
Sector
Industry
Phone
61 8 8150 7400
Address
200 GREENHILL ROAD, EASTWOOD SA
Compare BNOX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| BNOX | 0.289 | 4.87M | 0 | 0 | 0 | -3.2558 |
| VRTX | 447.13 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.99 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.16 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.68 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.55 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Bionomics Ltd Adr Stock (BNOX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-28-23 | Reiterated | Maxim Group | Buy |
| Jan-10-22 | Initiated | Berenberg | Buy |
| Jan-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-22 | Initiated | Evercore ISI | Outperform |
| Jan-10-22 | Initiated | H.C. Wainwright | Buy |
View All
Bionomics Ltd Adr Stock (BNOX) Latest News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.88% - MSN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 3.55% - MSN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.89% - MSN
Bionomics announces shareholder meeting for US re-domiciliation - Investing.com India
United States shares higher at close of trade; Dow Jones Industrial Average up 3.56% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 3.58% - MSN
United States shares higher at close of trade; Dow Jones Industrial Average up 0.89% - MSN
Why Bionomics (BNOX) Stock Is Up 100% Today - Benzinga
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Bionomics secures AUS$1M milestone payment from Carina Biotech - Investing.com India
Bionomics secures AUS$1M milestone payment from Carina Biotech By Investing.com - Investing.com UK
Here’s Why DENTSPLY Sirona Inc (NASDAQ: XRAY) Is An Attractive Investment Right Now - Stocks Register
BNOX stock touches 52-week low at $0.23 amid sharp decline By Investing.com - Investing.com South Africa
BNOX stock touches 52-week low at $0.23 amid sharp decline - Investing.com India
Tonix Pharmaceuticals Holding Corp (TNXP): An Important Analyst Insights - Stocks Register
Sprinklr Inc (NYSE: CXM) Up 1.53%: This Is What Analysts Are Now Forecasting - Stocks Register
AgEagle Aerial Systems Inc. (AMEX: UAVS): Blank Check On Growth? - Stocks Register
Bionomics to Present at the ThinkEquity Conference - GlobeNewswire Inc.
BNOX stock touches 52-week low at $0.23 amid sharp annual decline - Investing.com Australia
Bionomics announces director resignation - Investing.com India
Bionomics announces director resignation By Investing.com - Investing.com UK
Analyzing Ratios: Bionomics Ltd. ADR (BNOX)’s Financial Story Unveiled - The Dwinnex
Apeiron entities sell Bionomics shares worth $82,526 - Investing.com
Apeiron entities sell Bionomics shares worth $82,526 By Investing.com - Investing.com South Africa
Bionomics commences phase 3 trial in anxiety disorder - Investing.com
BNOX stock touches 52-week low at $0.39 amid sharp annual decline - Investing.com
Bionomics plans U.S. re-domiciliation for strategic growth - Investing.com India
Bionomics plans U.S. re-domiciliation for strategic growth By Investing.com - Investing.com South Africa
Bionomics Ltd. ADR Inc. (BNOX) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Market Watch: Bionomics Ltd. ADR (BNOX)’s Noteworthy Drop, Closing at 0.64 - The Dwinnex
Bionomics Ltd. ADR (BNOX) stock analysis: A simple moving average approach - US Post News
Ratio Analysis: Unpacking Bionomics Ltd. ADR (BNOX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Is it possible to buy Bionomics Ltd. ADR(BNOX) shares at a good price now? - US Post News
Investor’s Toolkit: Key Ratios for Assessing Bionomics Ltd. ADR (BNOX)’s Performance - The Dwinnex
Recursion Pharmaceuticals Inc (RXRX) Has Recovered 32.29% From Its Low: Is This The Beginning Of A Trend? - Stocks Register
An analyst sees good growth prospects for Bionomics Ltd. ADR (BNOX) - SETE News
Bionomics Ltd. ADR [BNOX] Stock trading around $0.83 per share: What’s Next? - The DBT News
Bionomics Ltd. ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Bionomics Ltd. ADR (BNOX) Stock: A Year of Decreases and Increases - The InvestChronicle
Nauticus Robotics Inc [KITT] Stock trading around $0.13 per share: What’s Next? - The DBT News
Chuy’s Holdings Inc [CHUY] fell -2.33% so far this year. What now? - The DBT News
Market cap of Kintara Therapeutics Inc [KTRA] reaches 15.16M – now what? - The DBT News
Bionomics Ltd. ADR Inc. (BNOX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Bionomics commences phase 3 trial for social anxiety treatment - Investing.com
Bionomics faces Nasdaq delisting over share price - Investing.com
Stock Market Recap: Bionomics Ltd. ADR (BNOX) Concludes at 0.69, a -2.76 Surge/Decline – DWinneX - The Dwinnex
Results from Bionomics Ltd. ADR (BNOX) show potential – US Post News - US Post News
Bionomics stock retains Buy rating from H.C. Wainwright By Investing.com - Investing.com
Bionomics Ltd. ADR's latest rating changes from various analysts – Knox Daily - Knox Daily
Closing Bell Recap: Bionomics Ltd. ADR (BNOX) Ends at 0.84, Reflecting a -14.97 Downturn – DWinneX - The Dwinnex
BNOX’s Stochastic Averages Dip: Analyzing Bionomics Ltd. ADR’s Stock Performance - The InvestChronicle
Bionomics Ltd Adr Stock (BNOX) Financials Data
There is no financial data for Bionomics Ltd Adr (BNOX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):